Magis Pharma Group SRL
Magis Pharma Group reported revenue of 868,488 € for the 2025 financial year (annual accounts filed with the NBB on 16 Jul 2026).
The score of Magis Pharma Group shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue -17 % Equity -95 % Total assets -22 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Magis Pharma Group's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 868,488 € | ||||
| Net result | −399,056 € | ||||
| Equity | 530,028 € | ||||
| Cash | 11,511 € | ||||
| EBITDA | −159,593 € | ||||
| Total assets | €13.0m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 16 Jul 2026
- Year ended 31 Dec 2024filed on 28 Oct 2025
- Year ended 31 Dec 2023filed on 26 Jun 2024
- Year ended 31 Dec 2022filed on 03 Aug 2023
- Year ended 31 Dec 2021filed on 29 Jun 2022
Magis Pharma Group's financial analysis
- Solvency4.1%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Magis Pharma Group
Magis Pharma Group's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0765.834.004
- VAT number
- BE0765834004
- Peppol
- Registered · 0208:0765834004 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 30 Mar 2021
- Registered office
- 2610 Antwerp
- Latest accounts
- 2025 · filed on 16 Jul 2026
- Activity
- Activities of holding companies (NACE 64210)
Magis Pharma Group (SRL) has been based in Antwerp since 2021, active in: activities of holding companies. For 2025, it reports revenue of 868,488 €, a net loss of 399,056 € and equity of 530,028 €. Its solvency stands at 4.1%, below the median of its sector (55.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Magis Pharma Group
Companies in the same business, of comparable size and area, outside its group.
- Biognost Filia Activities of holding companies Kortrijk · balance sheet €17.3m
- Vernacos Activities of holding companies Heist-op-den-Berg · balance sheet €13.0m
- Decura Pharma Activities of holding companies Ostend · balance sheet €12.0m
- Kemia Activities of holding companies Hoogstraten · balance sheet €8.89m
- A/S Holdco Activities of holding companies Asse · balance sheet €10.6m
- HDT Activities of holding companies Stabroek · balance sheet €10.6m
- VSF Management Business and other management consultancy activities Nandrin · balance sheet €11.3m
- JM Capital Activities of holding companies Ranst · balance sheet €23.2m
Frequently asked questions about Magis Pharma Group
What is the revenue of Magis Pharma Group?
According to the 2025 annual accounts filed with the NBB, the revenue of Magis Pharma Group amounts to 868,488 €.
What is the VAT number of Magis Pharma Group?
In Belgium, the VAT number is the company number prefixed with BE: BE0765834004 for Magis Pharma Group, if the company is VAT-registered. Its company number (CBE) is 0765.834.004.
Where is the registered office of Magis Pharma Group?
According to the CBE register, the registered office of Magis Pharma Group is in 2610 Antwerp.
What is the equity of Magis Pharma Group?
At the close of the 2025 financial year, the equity of Magis Pharma Group amounts to 530,028 €, a solvency of 4.1% of total assets.
Who manages Magis Pharma Group?
The register lists 5 active mandates at Magis Pharma Group. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Magis Pharma Group
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →